Reuters logo
BRIEF-Serimmune announces research, development collaboration agreement with subsidiary of Merck
June 20, 2017 / 5:20 PM / 6 months ago

BRIEF-Serimmune announces research, development collaboration agreement with subsidiary of Merck

June 20 (Reuters) - Serimmune Inc:

* Announced a research and development collaboration agreement with a subsidiary of Merck

* Under agreement terms Co will apply immune repertoire characterization platform to clinical and preclinical specimens provided by Merck

* Merck will lead preclinical and clinical development and commercialization of candidates identified from collaboration

* Serimmune will be eligible to receive development, regulatory milestone payments, tiered royalties on sales of any products resulting from collaboration Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below